Pages that link to "Q30356962"
Jump to navigation
Jump to search
The following pages link to Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada. (Q30356962):
Displaying 7 items.
- Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context (Q30151721) (← links)
- Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice (Q30392198) (← links)
- Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis (Q30398645) (← links)
- Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15. (Q30398670) (← links)
- Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials. (Q34485005) (← links)
- Optimizing antiviral therapy for influenza: understanding the evidence (Q38361244) (← links)
- Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness (Q57094433) (← links)